TOP CLASS HEALTHCARE, FI
Cartera
Este fondo se corresponde con los siguientes códigos ISIN: ES0179362001
Patrimonio | 5.195.593€ |
---|---|
Partícipes | 245 |
Patrimonio por partícipe | 21.206,50€ |
Cartera del fondo a 2017-12-31
El fondo invierte en 61 activos diferentes:
Activo | ISIN | Porcentaje |
---|---|---|
MERCK & CO. | US58933Y1055 | 4,72% |
JOHNSON & JOHNSON S | US4781601046 | 3,90% |
ROCHE HOLDG | CH0012032048 | 3,89% |
MEDTRONIC PLC | IE00BTN1Y115 | 3,84% |
HCA HOLDINGS INC | US40412C1018 | 3,68% |
PFIZER INC. | US7170811035 | 3,54% |
GILEAD SCIENCES | US3755581036 | 3,00% |
STRYKER CORP | US8636671013 | 2,81% |
ABBVIE INC | US00287Y1091 | 2,70% |
COTY INC -CL A | US2220702037 | 2,67% |
ANTHEM INC | US0367521038 | 2,51% |
NOVARTIS AG-ADR | US66987V1098 | 2,35% |
BRISTOL-MYERS | US1101221083 | 2,31% |
CIGNA CORP | US1255091092 | 2,27% |
AMGEN INC. | US0311621009 | 2,19% |
SHIRE PHARM GROUP -- NASDAQ | US82481R1068 | 2,17% |
CELGENE CORP | US1510201049 | 2,04% |
MYLAN NV -- NASDAQ | NL0011031208 | 2,01% |
REGENERON PHARMACEUTICALS | US75886F1075 | 1,89% |
THERMO FISHER SCIENTIFIC INC | US8835561023 | 1,86% |
LIFEPOINT HOSPITALS | US53219L1098 | 1,81% |
CHINA BIOLOGIC PRODUCTS INC | KYG215151047 | 1,76% |
DANAHER CORP | US2358511028 | 1,69% |
SANOFI | FR0000120578 | 1,57% |
AETNA INC NEW | US00817Y1082 | 1,51% |
MERCK KGAA | DE0006599905 | 1,51% |
ISHARES NASDAQ BIOTECH INDX | US4642875565 | 1,49% |
FIRST TRUST NYSE ARCA BIOTEC ETF | US33733E2037 | 1,39% |
ZIMMER BIOMET HOLDINGS INC | US98956P1021 | 1,35% |
ALLSCRIPTS HEALTHCARE SOLUTIONS | US01988P1084 | 1,34% |
JAZZ PHARMACEUTICALS PLC | IE00B4Q5ZN47 | 1,32% |
UNIVERSAL HEALTH SEVICES-B | US9139031002 | 1,27% |
ENVISION HEALTHCARE CORP | US29414D1000 | 1,16% |
RECKITT BENCKISER GROUP PLC (EUR) | GB00B24CGK77 | 1,08% |
ESTIA HEALTH LTD | AU000000EHE2 | 0,99% |
HORIZON PHARMA PLC | IE00BQPVQZ61 | 0,98% |
ASTRAZENECA | US0463531089 | 0,97% |
ARENA PHARMACEUTICALS INC | US0400476075 | 0,95% |
PRIMARY HEALTH CARE LTD | AU000000PRY5 | 0,95% |
PROTAGONIST THERAPEUTICS | US74366E1029 | 0,93% |
NEWLINK GENETICS CORP | US6515111077 | 0,91% |
ARRAY BIOPHARMA INC | US04269X1054 | 0,89% |
BIOGEN IDEC INC | US09062X1037 | 0,89% |
SERES THERAPEUTICS | US81750R1023 | 0,85% |
USANA HEALTH SCIENCES INC | US90328M1071 | 0,83% |
INTELLIA THERAPEUTICS | US45826J1051 | 0,81% |
CELLDEX THERAPEUTICS INC | US15117B1035 | 0,79% |
ALLERGAN PLC -- NYSE | IE00BY9D5467 | 0,78% |
RAMSAY HEALTH CARE LTD | AU000000RHC8 | 0,76% |
BLUEBIRD BIO | US09609G1004 | 0,75% |
INTERCEPT PHARMACEUTICALS IN | US45845P1084 | 0,73% |
INTRA-CELLULAR THERAPIES | US46116X1019 | 0,73% |
CENTENE CORPORATION | US15135B1017 | 0,70% |
TESARO INC | US8815691071 | 0,69% |
ACADIA PHARMACEUTICALS INC | US0042251084 | 0,67% |
GRIFOLS SA-ADR | US3984384087 | 0,64% |
JUNO THERAPEUTICS | US48205A1097 | 0,64% |
IRONWOOD PHARMACEUTICALS INC | US46333X1081 | 0,63% |
ULTRAGENYX PHARMACEUTICAL IN | US90400D1081 | 0,52% |
MALLINCKRODT PLC | IE00BBGT3753 | 0,50% |
COHERUS BIOSCIENCES INC | US19249H1032 | 0,37% |
Tenga en cuenta que el informe de cartera del fondo hace referencia a cierre del mercado del día y en ningún caso los activos que aparecen aquí están ponderados durante las sesiones del trimestre anterior
TOP CLASS HEALTHCARE, FI
Fondo de inversión armonizado gestionado por RENTA 4 GESTORA, S.G.I.I.C., S.A.
5,2M
patrimonio
245
partícipes
6, en una escala de 1 al 7
perfil de riesgo